Home > Insider Trading > Filing (0001649094-25-000006)

Filing Details

Accession Number:: 0001649094-25-000006
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-17 16:05:42
Reporting Period:: 2025-01-15

Accepted Time:: 2025-01-17 16:05:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649094	Vaxcyte Inc.	PCVX	Biological Products, (No Disgnostic Substances) (2836)	464233385

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1829111	Teri Loxam	C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-01-15	6,250	$22.70	13,425	No	4	M	Direct
Common Stock	Disposition	2025-01-15	146	$80.46	13,279	No	4	S	Direct
Common Stock	Disposition	2025-01-15	215	$81.53	13,064	No	4	S	Direct
Common Stock	Disposition	2025-01-15	1,136	$82.89	11,928	No	4	S	Direct
Common Stock	Disposition	2025-01-15	1,202	$83.93	10,726	No	4	S	Direct
Common Stock	Disposition	2025-01-15	1,043	$85.29	9,683	No	4	S	Direct
Common Stock	Disposition	2025-01-15	966	$86.26	8,717	No	4	S	Direct
Common Stock	Disposition	2025-01-15	1,013	$87.38	7,704	No	4	S	Direct
Common Stock	Disposition	2025-01-15	529	$88.54	7,175	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2025-01-15	6,250	$0.00	6,250	$22.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,250		2032-05-31	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024.
The price reported is a weighted-average price. The shares were sold at prices ranging from $80.32 to $80.48. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $81.36 to $81.735. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $82.455 to $83.42. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $83.51 to $84.37. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $84.83 to $85.73. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $85.89 to $86.59. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $86.89 to $87.75. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $87.915 to $88.91. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
Option is fully vested and exercisable.